Keywords
How to Cite
Copyright © | All rights reserved.
The journal holds the exclusive copyright for the publication of this article under the terms of Brazilian law 9610/98.
Partial reproduction
The use of parts of the texts, figures and questionnaire of the article is free, being mandatory the citation of the authors and journal.
Total reproduction
It is expressly prohibited and must be authorized by the journal.
Abstract
Objective: to describe the costs of hospitalizations with the use of peripheral vascular stents in the Brazilian public health system between the years 2008-2017. Methods: an ecological, retrospective study with time series analysis, obtained from the Department of Informatics of the Unified Health System (DATASUS) on hospitalizations and expenses in the use of vascular stent implants performed in peripheral arterial disease (PAD). Results: During the study period, a total of 36,543 hospitalizations for PAD were recorded. A rapid and progressive increase in stent use was observed between the years of the study, with the Southeast (45.7%) and South (36.8%) regions accounting for 82.5% of hospitalizations. Intraluminal angioplasty of extremity vessels with bare-metal stent was the most prevalent (70%) and had the highest total cost. Conclusion: The use of vascular stents has progressively increased between the years of the study, generating a significant impact on hospital occupancy and expenses.
References
AGÊNCIA NACIONAL DE SAÚDE SUPLEMENTAR DO BRASIL. Sala de Situação. 2022 [Acessado em 30 de março 2023]. Disponível em: https://www.gov.br/ans/pt-br/assuntos/noticias/numeros-do-setor/sala-de-situacao-ans-disponibiliza-dados-de-setembro
ALVIM RO, et al. Prevalence of peripheral artery disease and associated risk factors in a Brazilian rural population: the Baependi Heart Study. Int J Cardiovasc Sci., 2018; 31: 405-13.
ALZAMORA MT, et al. Incidence of peripheral arterial disease in the ARTPER population cohort after 5 years of follow-up. BMC Cardiovasc Disord., 2016; 16: 8.
CLAIR DG e BEACH JM. Strategies for managing aortoiliac occlusions: access, treatment and outcomes. Expert Rev Cardiovasc Ther., 2015; 13(5): 551–563.
CONTE SM, VALE PR. Peripheral Arterial Disease. Heart Lung and Circ., 2017; 27(4): 427-432.
DORMANDY JA e RUTHERFORD RB. Management of peripheral arterial disease (PAD): TASC Working Group: TransAtlantic Inter-Society Consensus (TASC). J Vasc Surg., 2000; 31: S1–S296.
DUDA SH, et al. Drug-eluting and bare nitinol stents for the treatment of atherosclerotic lesions in the superficial femoral artery : long-term results from the SIROCCO trial. J Endovasc Ther. 2006;13(6):701-10.
FANARI Z e WEINTRAUB WS. Cost-effectiveness of medical, endovascular and surgical management of peripheral vascular disease. Cardiovascular Revascularization Medicine, 2015; 16(7): 421–425.
FU X, et al. Angioplasty versus bypass surgery in patients with critical limb ischemia-a meta-analysis. Int J Clin Exp Med., 2015; 8(7): 10595-602.
GEIGER MA e GUILLAUMON AT. Tratamento da doença arterial obstrutiva periférica em território femoropoplíteo com stent primário: análise em até 24 meses. J Vasc Bras., 2019; 18: e20160104
GERHARD-HERMASNN et al. AHA/ACC Guideline on the Management of Patients With Lower Extremity Peripheral Artery Disease: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Circulation., 2016; 135(12): e686–e725.
HIRSCH AT. Treatment of peripheral arterial disease — extending “Intervention” to “Therapeutic Choice.”. N Engl J Med. 2006;354(18):1944-7.
KAKKAR AM e ABBOTT JD. Percutaneous Versus Surgical Management of Lower Extremity Peripheral Artery Disease. Curr. Atheroscler. Rep., 2015; 17(2): 2-9.
KATSANOS K, et al. Standards of Practice for Superficial Femoral and Popliteal Artery Angioplasty and Stenting. CardioVascular and Interventional Radiology. 2014; 37(3): 592–603.
KUDAGI VS e WHITE CJ. Endovascular stents: A review of their use in peripheral arterial disease. Am. J. Cardiovasc. Drugs. 2013; 13(3): 199–212.
LOBATO AC. Stents vasculares. In: Lobato AC. Cirurgia endovascular. São Paulo: Instituto de Cirurgia Vascular e Endovascular de São Paulo; 2006; 83-96.
MAKDISSE, M. et al. Prevalência e fatores de risco associados à doença arterial periférica no projeto corações do Brasil. Arq. Bras. Cardiol., 2008; 91(6): 402-414.
NASCIMENTO BR, et al. Trends in Procedure Type, Morbidity and In-Hospital Outcomes of Patients with Peripheral Artery Disease: Data from the Brazilian Public Health System. Ann. Vasc. Surg. 2016; 31: 143–151.
NGU NL, et al. A retrospective cost analysis of angioplasty compared to bypass surgery for lower limb arterial disease in an Australian tertiary health service. J Med Imaging Radiat Oncol. 2018;62(3):337-344.
NGUYEN BN, et al. Late outcomes of balloon angioplasty and angioplasty with selective stenting for superficial femoral-popliteal disease are equivalent. J Vasc Surg. 2011;54(4):1051-7.e1.
NORGREN L, et al. Inter-society consensus for the management of peripheral arterial disease (TASC II). J Vasc Surg. 2007; 45: S5–S67.
NUNES S e GOUVEIA C. Afinal, não era preciso amputar! Um caso clínico. Rev Port Med Geral Fam. 2018; 34(5): 307-11.
SCHILLINGER M, et al. Balloon angioplasty versus implantation of nitinol stents in the superficial femoral artery. N Engl J Med. 2006;354(18):1879-88.
SELVIN E e ERLINGER TP. Prevalence of and risk factors for peripheral arterial disease in the United States: results from the National Health and Nutrition Examination Survey, 1999-2000. Circulation, 2004; 110(6): 738-43.
VELESCU A, et al. Peripheral Arterial Disease Incidence and Associated Risk Factors in a Mediterranean Population-based Cohort. The Regicor Study. Eur J Vasc Endovasc Surg., 2016; 51(5): 696-705.
WOLOSKER N, et al. Epidemiological analysis of lower limb revascularization for peripheral arterial disease over 12 years on the public healthcare system in Brazil. J Vasc Bras. 2022;21:e20210215.